Furthermore, these inhibitory mechanisms may impede phagocytosis in wild type phagocytes that express SIRPα and CD47 of any cellular target on which CD47 is expressed (e.g., red blood cells [24], platelets [74] and tumor cells [75, 76]). The gene discussed is SIRPA; the disease is neoplasm.